These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 17989604

  • 1. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 2. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
    Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Buss S, Hardt S, Sack FU, Katus HA, Dengler TJ.
    Transplantation; 2009 Sep 27; 88(6):835-41. PubMed ID: 19920784
    [Abstract] [Full Text] [Related]

  • 3. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Sep 27; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 4. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 5. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 6. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
    Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO.
    Clin Res Cardiol; 2018 Feb 01; 107(2):138-147. PubMed ID: 29098378
    [Abstract] [Full Text] [Related]

  • 7. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK.
    J Cardiovasc Pharmacol Ther; 2013 Jul 01; 18(4):338-44. PubMed ID: 23426376
    [Abstract] [Full Text] [Related]

  • 8. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N.
    Therapie; 2009 Jul 01; 64(2):111-4. PubMed ID: 19664404
    [Abstract] [Full Text] [Related]

  • 9. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J.
    Methods Find Exp Clin Pharmacol; 2008 Oct 01; 30(8):633-41. PubMed ID: 19088948
    [Abstract] [Full Text] [Related]

  • 10. Ivabradine: beyond heart rate control.
    Riccioni G, Vitulano N, D'Orazio N.
    Adv Ther; 2009 Jan 01; 26(1):12-24. PubMed ID: 19165437
    [Abstract] [Full Text] [Related]

  • 11. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Jan 01; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 12. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Europace; 2013 Jan 01; 15(1):116-21. PubMed ID: 22772053
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS, Tardif JC.
    Am J Cardiol; 2010 Jan 01; 105(1):29-35. PubMed ID: 20102886
    [Abstract] [Full Text] [Related]

  • 14. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
    Celik O, Atasoy MM, Ertürk M, Yalçın AA, Aksu HU, Diker M, Aktürk IF, Atasoy I.
    Acta Radiol; 2014 Jul 01; 55(6):676-81. PubMed ID: 24052362
    [Abstract] [Full Text] [Related]

  • 15. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK, Narain VS, Dwivedi SK, Sethi R, Chandra S, Puri A, Saran RK.
    J Cardiovasc Pharmacol; 2015 Jun 01; 65(6):552-4. PubMed ID: 25636072
    [Abstract] [Full Text] [Related]

  • 16. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C, Cargnoni A, Francolini G, Parinello G, Ferrari R.
    Cardiovasc Res; 2009 Oct 01; 84(1):72-82. PubMed ID: 19477966
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Oct 01; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 18. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R, Ceconi C.
    Expert Rev Cardiovasc Ther; 2011 Aug 01; 9(8):959-73. PubMed ID: 21878041
    [Abstract] [Full Text] [Related]

  • 19. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK, Gray D, Purcell H.
    Adv Ther; 2009 Feb 01; 26(2):127-37. PubMed ID: 19259630
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
    Kaplinsky E, Comes FP, Urondo LS, Ayma FP.
    Cardiol J; 2010 Feb 01; 17(2):166-71. PubMed ID: 20544616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.